) is a Chinese biopharmaceutical company that focuses on the research, development, manufacture and commercialization of vaccines that protect against human infectious diseases. The company is based in Beijing, China. The company is listed on the NASDAQ but the exchange halted Sinovac's trading in February 2019 due to a proxy fight. - Source: Wikipedia
- News
- Policy
-
Commentary
- Commentary Main
- Corrections
- Editorials
- Letters
- Cheryl K. Chumley
- Kelly Sadler
- Jed Babbin
- Tom Basile
- Tim Constantine
- Joseph Curl
- Joseph R. DeTrani
- Don Feder
- Billy Hallowell
- Daniel N. Hoffman
- David Keene
- Robert Knight
- Gene Marks
- Clifford D. May
- Michael McKenna
- Stephen Moore
- Tim Murtaugh
- Peter Navarro
- Everett Piper
- Cal Thomas
- Scott Walker
- Miles Yu
- Black Voices
- Books
- Cartoons
- To the Republic
- Sports
- Sponsored
- Events
-
Video/Podcasts
- Corrections
- All Videos
- All Podcasts
- The Front Page
- Threat Status
- Politically Unstable
- The Sitdown with Alex Swoyer
- Bold & Blunt
- The Higher Ground
- Court Watch
- Victory Over Communism
- District of Sports
- Capitol Hill Show
- The Unregulated Podcast
- ForAmerica
- Washington Times Weekly
- God, Country & American Story
- Games
-
- Subscribe
- Sign In